New Data Analysis Supports GOCOVRI for Motor Complications for People With PD
10 Jun 2021 //
BUSINESSWIRE
Adamas` Parkinson`s drug gets US marketing authorisation for second indication
01 Feb 2021 //
PHARMAFILE
Adamas announces issuance of new U.S. patent for GOCOVRI
13 May 2020 //
GLOBENEWSWIRE
Gocovri™ (Amantadine) : Adamas Pharma, v. Sandoz
10 May 2018 //
PATENT LITIGATION